FDA: Devs can release digital products for psychiatric disorders without 510(k) submission during COVID-19 crisis
Mobi Health News
APRIL 16, 2020
A new guidance from the U.S. regulator relaxes a handful of requirements for these digital health devices, and clarifies the agency's long-term enforcement policy for low-risk wellness products.
Let's personalize your content